These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 10955778

  • 1. Synergistic antitumor effect of chemotherapy and antisense-mediated ablation of the cell cycle inhibitor p27KIP-1.
    Achenbach TV, Müller R, Slater EP.
    Clin Cancer Res; 2000 Aug; 6(8):3006-14. PubMed ID: 10955778
    [Abstract] [Full Text] [Related]

  • 2. Tumor growth inhibition in vivo and G2/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase.
    Berg RW, Werner M, Ferguson PJ, Postenka C, Vincent M, Koropatnick DJ, Behrend E.
    J Pharmacol Exp Ther; 2001 Aug; 298(2):477-84. PubMed ID: 11454908
    [Abstract] [Full Text] [Related]

  • 3. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
    Raju U, Ariga H, Koto M, Lu X, Pickett J, Valdecanas D, Mason KA, Milas L.
    Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211
    [Abstract] [Full Text] [Related]

  • 4. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma].
    Song Y, Shen K, Tang PP.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):761-4. PubMed ID: 18307904
    [Abstract] [Full Text] [Related]

  • 5. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G, D'Agnano I, Leonetti C, Perini R, Bucci B, Zon G, Calabretta B, Zupi G.
    Cancer Res; 1998 Jan 15; 58(2):283-9. PubMed ID: 9443406
    [Abstract] [Full Text] [Related]

  • 6. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y.
    Cancer Res; 2000 Oct 01; 60(19):5558-64. PubMed ID: 11034103
    [Abstract] [Full Text] [Related]

  • 7. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.
    Jung C, Motwani M, Kortmansky J, Sirotnak FM, She Y, Gonen M, Haimovitz-Friedman A, Schwartz GK.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):6052-61. PubMed ID: 14676132
    [Abstract] [Full Text] [Related]

  • 8. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
    Budak-Alpdogan T, Chen B, Warrier A, Medina DJ, Moore D, Bertino JR.
    Clin Cancer Res; 2009 Feb 15; 15(4):1232-40. PubMed ID: 19174488
    [Abstract] [Full Text] [Related]

  • 9. Rhabdoid tumor growth is inhibited by flavopiridol.
    Smith ME, Cimica V, Chinni S, Challagulla K, Mani S, Kalpana GV.
    Clin Cancer Res; 2008 Jan 15; 14(2):523-32. PubMed ID: 18223228
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
    Bible KC, Kaufmann SH.
    Cancer Res; 1997 Aug 15; 57(16):3375-80. PubMed ID: 9269999
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
    Spänkuch-Schmitt B, Wolf G, Solbach C, Loibl S, Knecht R, Stegmüller M, von Minckwitz G, Kaufmann M, Strebhardt K.
    Oncogene; 2002 May 09; 21(20):3162-71. PubMed ID: 12082631
    [Abstract] [Full Text] [Related]

  • 12. p27 modulates cell cycle progression and chemosensitivity in human malignant glioma.
    Naumann U, Weit S, Rieger L, Meyermann R, Weller M.
    Biochem Biophys Res Commun; 1999 Aug 11; 261(3):890-6. PubMed ID: 10441521
    [Abstract] [Full Text] [Related]

  • 13. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.
    Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Durkin JP, Mayer LD, LaCasse EC.
    Clin Cancer Res; 2003 Jul 11; 9(7):2826-36. PubMed ID: 12855663
    [Abstract] [Full Text] [Related]

  • 14. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

  • 15. Regulation of cyclin E and p27kip during mitosis in BALB/c 3T3 cells.
    Agrawal D, Dong F, Wang YZ, Kayda D, Pledger WJ.
    Cell Growth Differ; 1995 Oct 15; 6(10):1199-205. PubMed ID: 8845296
    [Abstract] [Full Text] [Related]

  • 16. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK, Singh RP, Agarwal C, Chan DC, Agarwal R.
    Clin Cancer Res; 2002 Nov 15; 8(11):3512-9. PubMed ID: 12429642
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Synergism of antitumor effects on ovarian carcinoma using autocatalytic caspase-3 combined with flavopiridol].
    Song Y, Shen K, Xu F.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct 15; 45(10):781-6. PubMed ID: 21176562
    [Abstract] [Full Text] [Related]

  • 19. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
    Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R.
    Oncogene; 2003 Nov 13; 22(51):8271-82. PubMed ID: 14614451
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS, Liu DS, Dai CW, Li RJ.
    Am J Hematol; 2006 Apr 13; 81(4):242-55. PubMed ID: 16550520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.